However, the plot thickened when we found yet another patient with the association of myopathy and a peculiar CNS dysfunction, namely, severe juvenile Parkinsonism (77). What we found strange and a little disconcerting was that this young man harbored the same previously unreported mutation (p.T378P)

that we had identified in our latest patient with pure myopathy (4). However, we recovered some confidence in genotype:phenotype correlation when Dr. Spiegel’s patient also developed severe Parkinsonian symptoms and signs. Although this is an n of 2 series, our findings raise two interesting questions. First, is there, in fact, a causal relationship between Inhibitors,research,lifescience,medical the T378P mutation and Parkinsonism? Second, PGK deficiency was suspected in both patients because they presented initially with Inhibitors,research,lifescience,medical exercise intolerance, cramps, and myoglobinuria: Parkinsonism was a surprising clinical development. One cannot help wondering whether in some patients with PGK deficiency juvenile Parkinson disease may precede and overshadow the myopathy, thus escaping diagnosis. Certainly, this association has to be kept in mind. GSD X (phosphoglycerate mutase [PGAM] deficiency) PGAM is a dimeric enzyme composed of a musclespecific (M) subunit and a brain-specific (B) subunit. Normal Inhibitors,research,lifescience,medical adult human muscle contains predominantly the MM homodimer, which accounts for about 95% of the total activity. Fourteen patients with PGAM deficiency

in muscle have been reported, of whom nine were African American (78, 79). Although the first reported patient could not be studied at the molecular level (80), all other African American patients harbored

the W78X mutation, at least in heterozygosity, suggesting a Inhibitors,research,lifescience,medical founder effect. The most striking Alvocidib peculiarity of GSD X is its common association with tubular Inhibitors,research,lifescience,medical aggregates (TAs), which were seen in the muscle biopsies of 5 patients (36%) whereas they have never been reported in other glycogenoses. TAs are ordered stacks of tubules originating from the sarcoplasmic reticulum. Although they are a nonspecific pathological change seen in diverse conditions, including exposure to drugs, toxins, and hypoxia, their association with PGAM deficiency does not appear to be casual although the specific trigger remains unknown. Conclusions As stated at the outset, we did not intend to review all the muscle glycogenoses, but only to out consider some conundrums still presented by “old” GSD. We have not considered Lafora disease because muscle involvement is overshadowed by the devastating encephalopathy. Likewise, we have not discussed some recently described glycogenoses, such as aldolase deficiency (81), β-enolase deficiency (82), and the two forms of glycogenosis type 0 (aglycogenosis?) (7, 8) because they have been described in single patients. Thus, although we discussed more the problems than the progress promised in the title, we hope our considerations are an adequate homage to Valerie Askanas and W. King Engel.